HelloBetter Selected As Technology Pioneer 2024 By The World Economic Forum

HelloBetter Selected As Technology Pioneer 2024 By The World Economic Forum

Berlin, Germany - June 6, 2024 - HelloBetter, a leading digital mental health company, has been selected by the World Economic Forum (WEF) as one of 100 companies to be part of the 2024 ‘Technology Pioneers’. This recognition highlights the company's leadership in using digital technology to deliver effective, accessible and scalable mental health solutions. The company's evidence-based digital programmes are designed to empower individuals to proactively manage their mental health, addressing a critical need by providing cost-effective care anytime, anywhere, with no waiting times. 

Each year, the Forum selects 100 early-stage startups from around the world that are at the forefront of developing new technologies and successfully deploying innovative solutions. These technology pioneers are given the unique opportunity to work with the world's top political, business, academic and cultural leaders to address pressing global issues. Alongside HelloBetter, healthcare companies Kintsugi from the USA, Westlake Omics from China and HealthPlix from India were also selected as Technology Pioneers.

"We are honoured to be recognised as a Technology Pioneer by the World Economic Forum," said Dr Hannes Klöpper, CEO and co-founder of HelloBetter. "This recognition is a testament to our commitment to improving mental health outcomes through innovative digital solutions. We look forward to leveraging the World Economic Forum's unique network to advance our mission and collaborate with global leaders to address the global mental health crisis - one of the most critical public health challenges of our time."

The Technology Pioneers community has a strong track record of identifying high-calibre companies that go on to make a significant impact. Past members include iconic companies such as Google, Twitter, AirBnB, Mozilla, Kickstarter, Palantir, Wikimedia and Spotify. 

To kick off the two-year programme, HelloBetter will attend the ‘Annual Meeting of the New Champions’ (AMNC), often referred to as the ‘Summer Davos’, which this year takes place from Dalian, China from June 25-27. The conference is an opportunity for the Technology Pioneers to connect with their peers, leading entrepreneurs, corporate leaders, academics and policymakers from around the world. The World Economic Forum invites all participants in the programme to leverage the Forum's extensive network to accelerate the development and deployment of their innovative solutions to improve the state of the world we live in.

For more information about HelloBetter and its innovative digital mental health solutions, please visit https://hellobetter.de .

About HelloBetter

HelloBetter is a leader in the field of digital mental health care and a global pioneer in digital mental health research. Founded in 2015 by Prof. Dr. David Ebert, Dr. Hanne Horvath, and Dr. Elena Heber, the company has established itself as an innovation leader in digital therapeutics. HelloBetter offers ten online therapy programs, addressing both common mental health conditions such as depression, insomnia, and panic disorders, as well as underserved conditions including vaginismus and chronic pain. Six of these programmes have received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) and are fully integrated into Germany's standard healthcare system, available free of charge to all publicly insured adults as prescription digital therapeutics (PDTx), also known as DiGA. In 2022, HelloBetter expanded internationally with the launch of HelloGina in the US market, offering specialised sexual wellness support for individuals with vaginismus. The company's innovation and potential were further validated in early 2023 with the prestigious 'breakthrough device designation' for Digital Therapeutic to treat Panic Disorder from the FDA. HelloBetter's scientific excellence is demonstrated through its unparalleled evidence base, comprising 30 randomised controlled trials on its commercial products, with the majority published in peer-reviewed journals. Headquartered across Berlin, Potsdam, and Hamburg, HelloBetter employs over 150 professionals dedicated to advancing digital mental healthcare. For more information, visit https://hellobetter.de/.

Press contact:
presse@hellobetter.de

More press releases